by TractManager | Feb 25, 2021 | News
The Food and Drug Administration (FDA) has granted approval for Amondys 45 (casimersen; Sarepta Therapeutics Inc.) injection for the treatment of Duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 45...
by TractManager | Feb 24, 2021 | News
The Food and Drug Administration (FDA) has announced a voluntary recall of unused Medtronic Valiant Navion thoracic stent graft systems. The Valiant Navion thoracic stent graft system is indicated for the endovascular repair of all lesions of the descending thoracic...
by TractManager | Feb 23, 2021 | Emerging Technology Report
Elivaldogene autotemcel (eli-cel) is a lentiviral-based gene therapy for treatment cerebral adrenoleukodystrophy (CALD).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Feb 23, 2021 | Emerging Technology Report
The WiSE CRT system is a wireless left ventricular pacing system that works with an implanted right ventricular pacemaker and/or defibrillator for patients in whom cardiac resynchronization therapy (CRT) is indicated. If you have a Hayes login, click here to view the...
by TractManager | Feb 22, 2021 | News
The Food and Drug Administration (FDA) has announced a recall of specific lots of the Boston Scientific EMBLEM S-ICD (Subcutaneous Implantable Cardioverter Defibrillator) due to a manufacturing error. The EMBLEM S-ICD is part of the Boston Scientific S-ICD System. The...
Recent Comments